MedTrace Logo

A Clinical Study on the Effectiveness of a Lacticaseibacillus Strain on Blood Cholesterol Levels

NCT06108505 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-10-31

No results posted yet for this study

Summary

This is a 12-week prospective, multicentre, randomised Phase 4 study to evaluate the effect of a wild type strain of Lacticaseibacillus in cholesterol of blood levels.

Conditions

  • Cholesterol Levels

Interventions

OTHER

Lacticaseibacillus with oats

Subjects will receive 7.5 gr of oats containing Lacticaseibacillus

OTHER

Plain oats

Subjects will receive 7.5 gr of plain oats

Sponsors & Collaborators

  • Democritus University of Thrace

    lead OTHER

Principal Investigators

  • Yiannis Kourkoutas · Democritus University of Thrace

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-04
Primary Completion
2023-10-31
Completion
2023-11-30

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06108505 on ClinicalTrials.gov